A decade ago a large part of Big Pharma gave up on one of humanity’s cruellest diseases. But then a new treatment showed promise
How a Swedish start-up reignited the search for an Alzheimer’s drug
Recent Posts
- Senate Democrats raise alarm over Kevin Warsh’s $100mn of ‘undisclosed’ assets
- Netflix founder Reed Hastings to step down from board
- US oil bosses warn Trump to stand firm against Iran’s Hormuz toll
- Israel and Lebanon agree 10-day ceasefire, Trump says
- Starmer and Kendall call for OnlyFans-style age checks on social media
